Rituximab Plus Fludarabine and Cyclophosphamide Prolongs Progression-Free Survival Compared With Fludarabine and Cyclophosphamide Alone in Previously Treated Chronic Lymphocytic Leukemia - Concepedia

Concepedia

Publication | Closed Access

Rituximab Plus Fludarabine and Cyclophosphamide Prolongs Progression-Free Survival Compared With Fludarabine and Cyclophosphamide Alone in Previously Treated Chronic Lymphocytic Leukemia

475

Citations

41

References

2010

Year

Tadeusz Robak, Anna Dmoszyńska, Philippe Solal‐Céligny, Krzysztof Warzocha, Javier Loscertales, John Catalano, B. V. Аfanasiev, Loree Larratt, Christian H. Geisler, Marco Montillo,

Journal of Clinical Oncology

Abstract

R-FC significantly improved the outcome of patients with previously treated CLL.

References

	Year	Citations

Page 1